

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.87273544 |
| 2 | positive regulation of macrophage differentiation (GO:0045651) | 6.36773323 |
| 3 | cytidine catabolic process (GO:0006216) | 6.17671782 |
| 4 | cytidine deamination (GO:0009972) | 6.17671782 |
| 5 | cytidine metabolic process (GO:0046087) | 6.17671782 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.24587468 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.17019553 |
| 8 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.94003732 |
| 9 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.92428015 |
| 10 | Peyers patch development (GO:0048541) | 4.83111429 |
| 11 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.83111429 |
| 12 | proteasome assembly (GO:0043248) | 4.79138960 |
| 13 | thalamus development (GO:0021794) | 4.33763343 |
| 14 | cardiolipin metabolic process (GO:0032048) | 4.23734571 |
| 15 | glucosamine-containing compound catabolic process (GO:1901072) | 4.22889912 |
| 16 | regulation of endothelial cell differentiation (GO:0045601) | 4.02709172 |
| 17 | cellular biogenic amine catabolic process (GO:0042402) | 3.99539869 |
| 18 | amine catabolic process (GO:0009310) | 3.99539869 |
| 19 | multicellular organism reproduction (GO:0032504) | 3.78144878 |
| 20 | polyamine biosynthetic process (GO:0006596) | 3.75065114 |
| 21 | response to gravity (GO:0009629) | 3.74140255 |
| 22 | regulation of macrophage differentiation (GO:0045649) | 3.71049718 |
| 23 | skeletal muscle adaptation (GO:0043501) | 3.67989785 |
| 24 | muscle atrophy (GO:0014889) | 3.64077883 |
| 25 | striated muscle atrophy (GO:0014891) | 3.58412242 |
| 26 | regulation of platelet aggregation (GO:0090330) | 3.51977270 |
| 27 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.50209690 |
| 28 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.50209690 |
| 29 | negative regulation of T cell apoptotic process (GO:0070233) | 3.49533458 |
| 30 | adenosine metabolic process (GO:0046085) | 3.42458109 |
| 31 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.41129391 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.38190532 |
| 33 | urate metabolic process (GO:0046415) | 3.37803135 |
| 34 | platelet dense granule organization (GO:0060155) | 3.37605436 |
| 35 | negative regulation of organelle assembly (GO:1902116) | 3.36110628 |
| 36 | amine biosynthetic process (GO:0009309) | 3.33927678 |
| 37 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.27693643 |
| 38 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.21030652 |
| 39 | cellular biogenic amine biosynthetic process (GO:0042401) | 3.20025603 |
| 40 | protein K6-linked ubiquitination (GO:0085020) | 3.19436220 |
| 41 | mismatch repair (GO:0006298) | 3.17839186 |
| 42 | polyamine metabolic process (GO:0006595) | 3.15934152 |
| 43 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.12844766 |
| 44 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.11240888 |
| 45 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.09412221 |
| 46 | nucleoside diphosphate catabolic process (GO:0009134) | 3.09152694 |
| 47 | natural killer cell activation (GO:0030101) | 3.04597229 |
| 48 | protein import into peroxisome matrix (GO:0016558) | 3.02814762 |
| 49 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.01519153 |
| 50 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99956741 |
| 51 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.98597954 |
| 52 | natural killer cell differentiation (GO:0001779) | 2.98542679 |
| 53 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.98025511 |
| 54 | regulation of B cell differentiation (GO:0045577) | 2.97288389 |
| 55 | regulation of thymocyte apoptotic process (GO:0070243) | 2.96500419 |
| 56 | tryptophan catabolic process (GO:0006569) | 2.94415102 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 2.94415102 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 2.94415102 |
| 59 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.91950436 |
| 60 | monocyte chemotaxis (GO:0002548) | 2.91376208 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 2.87321962 |
| 62 | reproduction (GO:0000003) | 2.86693926 |
| 63 | peroxisome fission (GO:0016559) | 2.83643810 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83314935 |
| 65 | tryptophan metabolic process (GO:0006568) | 2.76398233 |
| 66 | positive regulation of defense response to virus by host (GO:0002230) | 2.72196197 |
| 67 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.72148141 |
| 68 | negative regulation of heart rate (GO:0010459) | 2.70985409 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.70235450 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.70235450 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.66517921 |
| 72 | negative regulation of ligase activity (GO:0051352) | 2.66517921 |
| 73 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.63838638 |
| 74 | behavioral response to nicotine (GO:0035095) | 2.63013059 |
| 75 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.60522921 |
| 76 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.60522921 |
| 77 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.60522921 |
| 78 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.60307992 |
| 79 | S-adenosylmethionine metabolic process (GO:0046500) | 2.57689215 |
| 80 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.57613461 |
| 81 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.57567865 |
| 82 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.56771345 |
| 83 | mannosylation (GO:0097502) | 2.56228453 |
| 84 | sperm-egg recognition (GO:0035036) | 2.56120584 |
| 85 | kynurenine metabolic process (GO:0070189) | 2.56065369 |
| 86 | regulation of sensory perception of pain (GO:0051930) | 2.55445223 |
| 87 | regulation of sensory perception (GO:0051931) | 2.55445223 |
| 88 | aggressive behavior (GO:0002118) | 2.55410989 |
| 89 | regulation of platelet activation (GO:0010543) | 2.55047999 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.54197491 |
| 91 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.53250361 |
| 92 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.53250361 |
| 93 | positive regulation of cell killing (GO:0031343) | 2.52972759 |
| 94 | regulation of centriole replication (GO:0046599) | 2.50788796 |
| 95 | myoblast migration (GO:0051451) | 2.47455410 |
| 96 | cellular response to dexamethasone stimulus (GO:0071549) | 2.47444224 |
| 97 | positive regulation of humoral immune response (GO:0002922) | 2.46006110 |
| 98 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.44496139 |
| 99 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.44496139 |
| 100 | negative T cell selection (GO:0043383) | 2.44426620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.20584882 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 4.34696617 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.88019561 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.81759044 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.74436904 |
| 6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.64548114 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60909190 |
| 8 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.57484178 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.41114433 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13292513 |
| 11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12039386 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.06085501 |
| 13 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.03398345 |
| 14 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.97808297 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.95420484 |
| 16 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94029046 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.90187211 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82962947 |
| 19 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.82429879 |
| 20 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.81726741 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.76268248 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76074272 |
| 23 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.74673349 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.71538882 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.71022368 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68326019 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67901263 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.58026009 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52589801 |
| 30 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.51443651 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.49983014 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.49866484 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.47744204 |
| 34 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.45738349 |
| 35 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.43096618 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42656876 |
| 37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.39093118 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.38409189 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36822624 |
| 40 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.36031903 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.35684914 |
| 42 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33300495 |
| 43 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.33062339 |
| 44 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.33062339 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32042056 |
| 46 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31682500 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31262591 |
| 48 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30708752 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.28754844 |
| 50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.28383530 |
| 51 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24212235 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23813257 |
| 53 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.23293452 |
| 54 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.22815810 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21167260 |
| 56 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19707263 |
| 57 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.18323106 |
| 58 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.17974044 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.17465374 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17119886 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.16750695 |
| 62 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.15979973 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.14849584 |
| 64 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.14722274 |
| 65 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14719818 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.14616511 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13141219 |
| 68 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10973186 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10498095 |
| 70 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.10253790 |
| 71 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.09245669 |
| 72 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.09115636 |
| 73 | NFYB_21822215_ChIP-Seq_K562_Human | 1.08425078 |
| 74 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08308561 |
| 75 | AR_20517297_ChIP-Seq_VCAP_Human | 1.07453993 |
| 76 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06540395 |
| 77 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.04749217 |
| 78 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03918451 |
| 79 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.03448350 |
| 80 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02947005 |
| 81 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.02713631 |
| 82 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01136814 |
| 83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00367737 |
| 84 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99770921 |
| 85 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.98082885 |
| 86 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97769384 |
| 87 | TBL1_22424771_ChIP-Seq_293T_Human | 0.96783093 |
| 88 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96012612 |
| 89 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.95843453 |
| 90 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.95526075 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95399029 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.95209639 |
| 93 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.95026379 |
| 94 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.94430030 |
| 95 | NCOR_22424771_ChIP-Seq_293T_Human | 0.94017519 |
| 96 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.93751962 |
| 97 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.93102268 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.90774057 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90693714 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90597718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 3.99511646 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 3.73316632 |
| 3 | MP0003878_abnormal_ear_physiology | 3.03458242 |
| 4 | MP0005377_hearing/vestibular/ear_phenot | 3.03458242 |
| 5 | MP0002736_abnormal_nociception_after | 2.95713697 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 2.82827377 |
| 7 | MP0005083_abnormal_biliary_tract | 2.78046044 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.77294732 |
| 9 | MP0005671_abnormal_response_to | 2.69663965 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.45478873 |
| 11 | MP0003252_abnormal_bile_duct | 2.39670920 |
| 12 | MP0003724_increased_susceptibility_to | 2.31739867 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.25537155 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.24211207 |
| 15 | MP0003646_muscle_fatigue | 2.22030344 |
| 16 | MP0003786_premature_aging | 2.20379010 |
| 17 | MP0005645_abnormal_hypothalamus_physiol | 2.17968776 |
| 18 | MP0003011_delayed_dark_adaptation | 2.10130683 |
| 19 | MP0008057_abnormal_DNA_replication | 2.09347484 |
| 20 | MP0009764_decreased_sensitivity_to | 1.96445264 |
| 21 | MP0003195_calcinosis | 1.92331833 |
| 22 | MP0008004_abnormal_stomach_pH | 1.87459246 |
| 23 | MP0004036_abnormal_muscle_relaxation | 1.87420690 |
| 24 | MP0003718_maternal_effect | 1.81262644 |
| 25 | MP0005365_abnormal_bile_salt | 1.71834050 |
| 26 | MP0004043_abnormal_pH_regulation | 1.65904917 |
| 27 | MP0008872_abnormal_physiological_respon | 1.63686201 |
| 28 | MP0005410_abnormal_fertilization | 1.61500848 |
| 29 | MP0003959_abnormal_lean_body | 1.60905292 |
| 30 | MP0000685_abnormal_immune_system | 1.58551700 |
| 31 | MP0002148_abnormal_hypersensitivity_rea | 1.53543054 |
| 32 | MP0001835_abnormal_antigen_presentation | 1.52423337 |
| 33 | MP0009785_altered_susceptibility_to | 1.46475108 |
| 34 | MP0010094_abnormal_chromosome_stability | 1.39725506 |
| 35 | MP0000427_abnormal_hair_cycle | 1.39430065 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.31256534 |
| 37 | MP0002006_tumorigenesis | 1.29568033 |
| 38 | MP0002269_muscular_atrophy | 1.28390972 |
| 39 | MP0002277_abnormal_respiratory_mucosa | 1.28017776 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.24030767 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.20174757 |
| 42 | MP0005000_abnormal_immune_tolerance | 1.16408703 |
| 43 | MP0001664_abnormal_digestion | 1.15812152 |
| 44 | MP0004147_increased_porphyrin_level | 1.15168168 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.14688004 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.11590239 |
| 47 | MP0002160_abnormal_reproductive_system | 1.08935002 |
| 48 | MP0009697_abnormal_copulation | 1.07512585 |
| 49 | MP0004084_abnormal_cardiac_muscle | 1.07472849 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.05807622 |
| 51 | MP0001727_abnormal_embryo_implantation | 1.04096978 |
| 52 | MP0001800_abnormal_humoral_immune | 1.01240017 |
| 53 | MP0002163_abnormal_gland_morphology | 1.00220884 |
| 54 | MP0001881_abnormal_mammary_gland | 0.99857006 |
| 55 | MP0002638_abnormal_pupillary_reflex | 0.98941956 |
| 56 | MP0002095_abnormal_skin_pigmentation | 0.96894976 |
| 57 | MP0001243_abnormal_dermal_layer | 0.95995216 |
| 58 | MP0000749_muscle_degeneration | 0.95471488 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.94953381 |
| 60 | MP0001661_extended_life_span | 0.94721069 |
| 61 | MP0002132_abnormal_respiratory_system | 0.93746470 |
| 62 | MP0000747_muscle_weakness | 0.93368491 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 0.92338440 |
| 64 | MP0001765_abnormal_ion_homeostasis | 0.91531688 |
| 65 | MP0000230_abnormal_systemic_arterial | 0.90178989 |
| 66 | MP0005379_endocrine/exocrine_gland_phen | 0.88486393 |
| 67 | MP0005387_immune_system_phenotype | 0.88433379 |
| 68 | MP0001790_abnormal_immune_system | 0.88433379 |
| 69 | MP0001905_abnormal_dopamine_level | 0.87582707 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.87493710 |
| 71 | MP0003045_fibrosis | 0.86223483 |
| 72 | MP0001502_abnormal_circadian_rhythm | 0.85303869 |
| 73 | MP0002723_abnormal_immune_serum | 0.85192064 |
| 74 | MP0005389_reproductive_system_phenotype | 0.83719296 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 0.82566025 |
| 76 | MP0002234_abnormal_pharynx_morphology | 0.82527637 |
| 77 | MP0003763_abnormal_thymus_physiology | 0.80756491 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.80496972 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.79888437 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.77877873 |
| 81 | MP0002106_abnormal_muscle_physiology | 0.76782018 |
| 82 | MP0002089_abnormal_postnatal_growth/wei | 0.76747629 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.75985347 |
| 84 | MP0001485_abnormal_pinna_reflex | 0.75569599 |
| 85 | MP0005025_abnormal_response_to | 0.75506476 |
| 86 | MP0002398_abnormal_bone_marrow | 0.74737701 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.74017193 |
| 88 | MP0003137_abnormal_impulse_conducting | 0.73649304 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.72688592 |
| 90 | MP0002405_respiratory_system_inflammati | 0.72282860 |
| 91 | MP0002452_abnormal_antigen_presenting | 0.72261305 |
| 92 | MP0000627_abnormal_mammary_gland | 0.72062953 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.71698208 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.70659485 |
| 95 | MP0001986_abnormal_taste_sensitivity | 0.70651430 |
| 96 | MP0005620_abnormal_muscle_contractility | 0.69679741 |
| 97 | MP0001819_abnormal_immune_cell | 0.69588153 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.69418500 |
| 99 | MP0009745_abnormal_behavioral_response | 0.68884365 |
| 100 | MP0005266_abnormal_metabolism | 0.67933481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.26240308 |
| 2 | IgG deficiency (HP:0004315) | 3.86661499 |
| 3 | Spontaneous hematomas (HP:0007420) | 3.85556178 |
| 4 | 3-Methylglutaconic aciduria (HP:0003535) | 3.77454465 |
| 5 | Congenital stationary night blindness (HP:0007642) | 3.67320705 |
| 6 | Palpebral edema (HP:0100540) | 3.55420230 |
| 7 | Severe combined immunodeficiency (HP:0004430) | 3.50436175 |
| 8 | Rhabdomyolysis (HP:0003201) | 3.41196164 |
| 9 | Petechiae (HP:0000967) | 3.26993045 |
| 10 | Conjunctival telangiectasia (HP:0000524) | 3.24260996 |
| 11 | Thyroiditis (HP:0100646) | 3.18636406 |
| 12 | Acute necrotizing encephalopathy (HP:0006965) | 3.15638048 |
| 13 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.14663484 |
| 14 | Myoglobinuria (HP:0002913) | 3.06212874 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.05828633 |
| 16 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.01473306 |
| 17 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.01414910 |
| 18 | T lymphocytopenia (HP:0005403) | 2.93334036 |
| 19 | Acute encephalopathy (HP:0006846) | 2.90566695 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 2.81252755 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 2.81252755 |
| 22 | Tongue fasciculations (HP:0001308) | 2.76666208 |
| 23 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.74864902 |
| 24 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.74112966 |
| 25 | Increased IgM level (HP:0003496) | 2.73600471 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 2.71670323 |
| 27 | Pancreatic cysts (HP:0001737) | 2.65936254 |
| 28 | Progressive macrocephaly (HP:0004481) | 2.65868588 |
| 29 | Increased CSF lactate (HP:0002490) | 2.65765686 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.62880410 |
| 31 | Mitochondrial inheritance (HP:0001427) | 2.62576781 |
| 32 | Congenital, generalized hypertrichosis (HP:0004540) | 2.60418025 |
| 33 | Combined immunodeficiency (HP:0005387) | 2.58266037 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.57693474 |
| 35 | Type II lissencephaly (HP:0007260) | 2.57256963 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.52751735 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.48272319 |
| 38 | Albinism (HP:0001022) | 2.47525501 |
| 39 | Malignant hyperthermia (HP:0002047) | 2.46918186 |
| 40 | True hermaphroditism (HP:0010459) | 2.42351987 |
| 41 | Nephronophthisis (HP:0000090) | 2.41843503 |
| 42 | Nemaline bodies (HP:0003798) | 2.41123148 |
| 43 | Epistaxis (HP:0000421) | 2.37360899 |
| 44 | Periorbital edema (HP:0100539) | 2.33483455 |
| 45 | Agitation (HP:0000713) | 2.32935346 |
| 46 | Muscle fibrillation (HP:0010546) | 2.32204461 |
| 47 | Hypoplasia of the thymus (HP:0000778) | 2.31379469 |
| 48 | Retinal dysplasia (HP:0007973) | 2.30423775 |
| 49 | Hepatic necrosis (HP:0002605) | 2.29991048 |
| 50 | Increased serum lactate (HP:0002151) | 2.27328788 |
| 51 | Abolished electroretinogram (ERG) (HP:0000550) | 2.26087307 |
| 52 | Facial edema (HP:0000282) | 2.25739800 |
| 53 | Pulmonary fibrosis (HP:0002206) | 2.25610041 |
| 54 | Abnormality of T cells (HP:0002843) | 2.22474180 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.21620724 |
| 56 | Brittle hair (HP:0002299) | 2.20218079 |
| 57 | Purpura (HP:0000979) | 2.14641944 |
| 58 | Cerebral edema (HP:0002181) | 2.14538980 |
| 59 | Abnormality of the labia minora (HP:0012880) | 2.14210017 |
| 60 | Gingival bleeding (HP:0000225) | 2.12405500 |
| 61 | Respiratory failure (HP:0002878) | 2.11285163 |
| 62 | Nausea (HP:0002018) | 2.10725337 |
| 63 | Autoimmune hemolytic anemia (HP:0001890) | 2.08299965 |
| 64 | Attenuation of retinal blood vessels (HP:0007843) | 2.06609640 |
| 65 | Increased intramyocellular lipid droplets (HP:0012240) | 2.03773635 |
| 66 | Gaze-evoked nystagmus (HP:0000640) | 2.02100990 |
| 67 | Intrahepatic cholestasis (HP:0001406) | 2.01696015 |
| 68 | Chronic diarrhea (HP:0002028) | 2.00599890 |
| 69 | Thyroid-stimulating hormone excess (HP:0002925) | 1.97902632 |
| 70 | Generalized aminoaciduria (HP:0002909) | 1.97722649 |
| 71 | Dysautonomia (HP:0002459) | 1.93481018 |
| 72 | Menorrhagia (HP:0000132) | 1.93365465 |
| 73 | Fair hair (HP:0002286) | 1.92022323 |
| 74 | Anhidrosis (HP:0000970) | 1.91657997 |
| 75 | Late onset (HP:0003584) | 1.90098420 |
| 76 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89111483 |
| 77 | Severe visual impairment (HP:0001141) | 1.86477899 |
| 78 | Symptomatic seizures (HP:0011145) | 1.85118722 |
| 79 | Round ear (HP:0100830) | 1.84953341 |
| 80 | Aplastic anemia (HP:0001915) | 1.84409840 |
| 81 | Constricted visual fields (HP:0001133) | 1.84188122 |
| 82 | Abnormality of eosinophils (HP:0001879) | 1.83991863 |
| 83 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83926107 |
| 84 | Lactic acidosis (HP:0003128) | 1.83828840 |
| 85 | Hematochezia (HP:0002573) | 1.83765251 |
| 86 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.83721784 |
| 87 | Small hand (HP:0200055) | 1.82776183 |
| 88 | Hypoproteinemia (HP:0003075) | 1.82366274 |
| 89 | Muscle fiber inclusion bodies (HP:0100299) | 1.79780698 |
| 90 | Abnormality of the renal cortex (HP:0011035) | 1.78125184 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 1.77374743 |
| 92 | Hyperalaninemia (HP:0003348) | 1.77374743 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.77374743 |
| 94 | Inability to walk (HP:0002540) | 1.77253189 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 1.76458686 |
| 96 | Type I transferrin isoform profile (HP:0003642) | 1.76382100 |
| 97 | Prolonged bleeding time (HP:0003010) | 1.75265277 |
| 98 | Absent phalangeal crease (HP:0006109) | 1.73244434 |
| 99 | Gonadotropin excess (HP:0000837) | 1.72509263 |
| 100 | Distal arthrogryposis (HP:0005684) | 1.71307831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.86871779 |
| 2 | TIE1 | 4.44649796 |
| 3 | MAPKAPK3 | 3.37000635 |
| 4 | NME1 | 3.02417981 |
| 5 | KDR | 2.81878933 |
| 6 | NUAK1 | 2.61156180 |
| 7 | PIM2 | 2.54801225 |
| 8 | ARAF | 2.51857453 |
| 9 | PHKG1 | 2.43177729 |
| 10 | PHKG2 | 2.43177729 |
| 11 | TSSK6 | 2.40393940 |
| 12 | FRK | 2.36185238 |
| 13 | TEC | 2.34333243 |
| 14 | GRK1 | 2.20753891 |
| 15 | BUB1 | 2.15312509 |
| 16 | ZAK | 2.09550720 |
| 17 | ADRBK2 | 2.05927001 |
| 18 | EIF2AK1 | 1.95371181 |
| 19 | BCKDK | 1.74901405 |
| 20 | EIF2AK3 | 1.73310347 |
| 21 | FES | 1.68681943 |
| 22 | TESK2 | 1.55987205 |
| 23 | LIMK1 | 1.52757302 |
| 24 | NEK1 | 1.48047605 |
| 25 | TLK1 | 1.41284457 |
| 26 | TAOK3 | 1.39100262 |
| 27 | MST4 | 1.39015803 |
| 28 | VRK2 | 1.32794673 |
| 29 | MAP3K10 | 1.29700096 |
| 30 | DAPK1 | 1.28034528 |
| 31 | MYLK | 1.17832857 |
| 32 | TESK1 | 1.14176566 |
| 33 | PTK2B | 1.09047285 |
| 34 | BMPR1B | 1.03272678 |
| 35 | OBSCN | 1.01535458 |
| 36 | CSNK1G3 | 1.01274009 |
| 37 | MAP3K12 | 0.96994380 |
| 38 | PRKCI | 0.95746670 |
| 39 | PLK3 | 0.94134660 |
| 40 | CSNK1A1L | 0.91504871 |
| 41 | MAP4K1 | 0.90634171 |
| 42 | PLK2 | 0.88930860 |
| 43 | RAF1 | 0.87131952 |
| 44 | GRK5 | 0.85850034 |
| 45 | ALK | 0.83203804 |
| 46 | SYK | 0.82880856 |
| 47 | BRAF | 0.78580680 |
| 48 | WNK4 | 0.77782391 |
| 49 | KIT | 0.76485738 |
| 50 | LMTK2 | 0.76055923 |
| 51 | STK16 | 0.74059603 |
| 52 | SCYL2 | 0.73383733 |
| 53 | CSNK1G2 | 0.71461832 |
| 54 | CSNK1G1 | 0.71368306 |
| 55 | PIK3CA | 0.63841587 |
| 56 | INSRR | 0.63602339 |
| 57 | EIF2AK2 | 0.63441626 |
| 58 | ATR | 0.62445976 |
| 59 | ADRBK1 | 0.57953748 |
| 60 | TGFBR2 | 0.57925763 |
| 61 | TGFBR1 | 0.57200061 |
| 62 | TRPM7 | 0.54512451 |
| 63 | TBK1 | 0.53260839 |
| 64 | PRKCQ | 0.52784560 |
| 65 | TNK2 | 0.52525887 |
| 66 | PRKCE | 0.51909879 |
| 67 | CSF1R | 0.49735929 |
| 68 | GRK6 | 0.49628030 |
| 69 | VRK1 | 0.49267785 |
| 70 | IRAK4 | 0.49130886 |
| 71 | PAK4 | 0.49057024 |
| 72 | OXSR1 | 0.46585232 |
| 73 | PLK4 | 0.45798515 |
| 74 | JAK3 | 0.45362503 |
| 75 | MAP4K2 | 0.44402815 |
| 76 | AURKA | 0.43840653 |
| 77 | PAK1 | 0.40229617 |
| 78 | BMX | 0.38770885 |
| 79 | IGF1R | 0.38116687 |
| 80 | CDK8 | 0.37743566 |
| 81 | PBK | 0.37228821 |
| 82 | IKBKE | 0.37058548 |
| 83 | PRKCA | 0.36741725 |
| 84 | STK39 | 0.36209246 |
| 85 | CHEK2 | 0.35041527 |
| 86 | GRK7 | 0.34163715 |
| 87 | ITK | 0.33433133 |
| 88 | CAMK2A | 0.33150541 |
| 89 | CDC7 | 0.32777842 |
| 90 | LYN | 0.31375468 |
| 91 | MAPKAPK5 | 0.30436507 |
| 92 | LCK | 0.30026819 |
| 93 | ACVR1B | 0.29868469 |
| 94 | CSNK2A1 | 0.29605815 |
| 95 | MAPK13 | 0.29277954 |
| 96 | SRPK1 | 0.28740816 |
| 97 | PRKCG | 0.28705745 |
| 98 | PDK2 | 0.28523224 |
| 99 | ZAP70 | 0.28384348 |
| 100 | PIM1 | 0.27745084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.12732997 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.35530730 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.86849120 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.60400807 |
| 5 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.55509243 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.52265740 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.41889338 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.35097857 |
| 9 | DNA replication_Homo sapiens_hsa03030 | 2.30204697 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00788077 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.00506040 |
| 12 | Mismatch repair_Homo sapiens_hsa03430 | 1.93641280 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 1.72534666 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.71371326 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70929936 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.66051655 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61041772 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56784653 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55264782 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54908168 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53966992 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53039277 |
| 23 | Sulfur relay system_Homo sapiens_hsa04122 | 1.50662191 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.50579317 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.47699762 |
| 26 | Asthma_Homo sapiens_hsa05310 | 1.47198224 |
| 27 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.41892296 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41476793 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.39364135 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.38415336 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.33721669 |
| 32 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.31227332 |
| 33 | Phototransduction_Homo sapiens_hsa04744 | 1.25423331 |
| 34 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.23410711 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23229905 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.22026750 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18373986 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.12589944 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09275726 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08826999 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07673246 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07237485 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02873062 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.01674279 |
| 45 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99891507 |
| 46 | Base excision repair_Homo sapiens_hsa03410 | 0.97555522 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97030673 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95096853 |
| 49 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92375912 |
| 50 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.91917180 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.91702324 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91332803 |
| 53 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.89450764 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.88117780 |
| 55 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.85158684 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.83767121 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.83516091 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82143267 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81303061 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.80147282 |
| 61 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78389911 |
| 62 | Morphine addiction_Homo sapiens_hsa05032 | 0.77883458 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 0.77476382 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76576474 |
| 65 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.75271160 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75100048 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73651763 |
| 68 | Platelet activation_Homo sapiens_hsa04611 | 0.69960875 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.69001478 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67723462 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.67489313 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65212091 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63538850 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.63266435 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.55173983 |
| 76 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.53778537 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.52612392 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.52403165 |
| 79 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52194771 |
| 80 | Salivary secretion_Homo sapiens_hsa04970 | 0.51317273 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50667992 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.48540326 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47451927 |
| 84 | Long-term depression_Homo sapiens_hsa04730 | 0.46739657 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46053839 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45622944 |
| 87 | RNA transport_Homo sapiens_hsa03013 | 0.45226962 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44932343 |
| 89 | Measles_Homo sapiens_hsa05162 | 0.43895856 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41968452 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41575050 |
| 92 | Viral myocarditis_Homo sapiens_hsa05416 | 0.39920012 |
| 93 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38920957 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38490122 |
| 95 | RNA degradation_Homo sapiens_hsa03018 | 0.37840897 |
| 96 | Circadian entrainment_Homo sapiens_hsa04713 | 0.35924161 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35255554 |
| 98 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34323085 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32606636 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.32193533 |

